Safety of and Immune Response to a DNA HIV Vaccine Followed By Boosting With One of Two Serotypes of Adenoviral Vector HIV Vaccine in Healthy Adults

NCT00472719 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

17

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: VRC-HIVADV027-00-VP
BIOLOGICAL: VRC-HIVADV038-00-VP
BIOLOGICAL: VRC-HIVDNA044-00-VP

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]